Treatment, tuberculosis, and human leukocyte antigen
- PMID: 12359643
- DOI: 10.1164/rccm.2207001
Treatment, tuberculosis, and human leukocyte antigen
Comment on
-
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment.Am J Respir Crit Care Med. 2002 Oct 1;166(7):916-9. doi: 10.1164/rccm.2108091. Am J Respir Crit Care Med. 2002. PMID: 12359646 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
